{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:17:34Z","timestamp":1793377054537,"version":"4.5.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":132,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222049\/Z\/20\/Z"],"award-info":[{"award-number":["222049\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["MGU0552"],"award-info":[{"award-number":["MGU0552"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Are recombinant FSH (rFSH) and hCG effective therapies for promoting testicular growth and spermatogenesis in male adolescents and young adults with gonadotropin deficiency?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Combined gonadotropin therapy is effective in inducing puberty and promoting spermatogenesis in male adolescents and young adults with gonadotropin deficiency and has the potential to improve adult outcomes relating to both fertility and quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Deficiency of pituitary gonadotropins (LH and FSH) due to hypogonadotropic hypogonadism (HH) can result in poor testicular development, low testicular volumes, micropenis and cryptorchidism. Inadequate hormonal replacement can lead to long-term issues, including subfertility or infertility, and reduced quality of life. Exogenous testosterone for pubertal induction can elevate serum testosterone concentrations and induce virilization, but it does not promote testicular development nor induce spermatogenesis. Fertility and testes growth remain primary concerns for patients seeking treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>We conducted a retrospective observational review of male adolescents and young adults with gonadotropin deficiency and seeking puberty replacement therapy at two large tertiary centre hospitals in London, UK, from 2010 to 2024.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>A total of 35 males, with diagnosis of congenital hypogonadotropic hypogonadism (CHH: n\u2009=\u200923; further subdivided into those with partial [pHH: n\u2009=\u20098] and those with complete gonadotropin deficiency [cHH: n\u2009=\u200915]), acquired HH (AHH: n\u2009=\u20094) or Kallmann syndrome (KS: n\u2009=\u20098), received combined gonadotropin therapy. We assessed testicular growth and semen quality post-treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>The majority of patients were referred for pubertal delay, alone or in combination with cryptorchidism, micropenis or microorchidism. Out of 35 patients, 22 (63%) had previously received testosterone, and the median age at gonadotropin treatment initiation was 15.8\u2009years (range: 11.8\u201322.7). Semen analysis was obtained in 18 out of 19 patients who had received gonadotropin therapy for a median treatment duration of 21.1\u2009months (range: 4.5\u201366.9) for rFSH and 19.5\u2009months (range: 8.3\u201361.1) for hCG. The median sperm count on semen analysis was 8.9 \u00d7 106\/ml (range: 0.0\u201354.9). Significant increases were noted in testicular volume (median change after therapy: 10.5\u2009ml [95% CI 9.5\u201313.6], P\u2009&amp;lt;\u20090.0001), testosterone (median increase: 25.7\u2009nmol\/l [95% CI 19.8\u201331.5], P\u2009&amp;lt;\u20090.0001) and inhibin B levels (67.7\u2009pg\/ml [95% CI 18.4\u201386.7], P\u2009=\u20090.0008).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The relatively low representation of patients with acquired HH in our study emphasizes the need to extrapolate the findings with caution in this specific subgroup of adolescent males with HH. The study is also an observational one, therefore meaning that some outcomes (such as change in inhibin B concentration) were not collected routinely and not reported for all patients. The observational nature of the study design also accounts for the differences in doses and duration observed in gonadotropin therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>The treatment of adult male infertility is particularly difficult in severe forms of gonadotropin deficiency, where there has been no testicular stimulation during mini-puberty or puberty. Appropriate hormonal replacement in puberty with combined gonadotropins can induce testicular maturation and spermatogenesis, but data are limited and at present, there is no international consensus on best practice regimens in adolescent and young adult males. Our treatment protocol induced testicular growth and caused increases in serum testosterone and Sertoli cell biomarkers, and spermatogenesis in 15\/18 of patients who had completed semen analysis. This indicates the potential to substantially improve the reproductive, physical, and psychological health of patients who have a significant and unmet need for adequate hormonal replacement during puberty. The study described here included patients with diverse forms of HH (congenital, acquired, complete, and partial HH), thereby providing encouraging results across a variety of subjects with impaired puberty facing increased odds of fertility problems in adulthood. Additionally, we observed similar sperm counts between those who received exogenous testosterone treatment prior to gonadotropin therapy and those who began directly on gonadotropins for pubertal induction. This last finding is aligned with previous data and may help to reassure paediatric endocrinologists with limited access to rFSH or hCG that the use of exogenous testosterone to induce androgen-dependent changes in patients seeking treatment for pubertal delay is unlikely to compromise spermatogenic potential, should gonadotropins become available at a later stage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>S.C. was funded by an ESPE Early Career Scientific Development Grant. S.R.H. was funded by the Wellcome Trust (222049\/Z\/20\/Z) and Barts Charity [MGU0552]. K.N.Y. was employed under the NIHR Specialist Foundation Programme. F.d.A. was funded by the student traineeship, University of Rome \u2018Tor Vergata\u2019, an Erasmus Grant and an ESPE Early Career Scientific Development Grant. E.C.A. was funded by an NIHR Academic Clinical Fellowship (ACF-2021-19-002). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR, NHS, or the UK Department of Health and Social Care. G.B. received an ESPE Mid-Career Research Fellowship to enable the development of the clinical treatment schedule. The authors have no conflicting interests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/hropen\/hoaf026","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:50:44Z","timestamp":1747147844000},"source":"Crossref","is-referenced-by-count":12,"title":["Effect of pubertal induction with combined gonadotropin therapy on testes development and spermatogenesis in males with gonadotropin deficiency: a cohort study"],"prefix":"10.1093","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8073-2046","authenticated-orcid":false,"given":"Sebastian","family":"Castro","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]},{"name":"Centro de Investigaciones Endocrinol\u00f3gicas \u201cDr. C\u00e9sar Bergad\u00e1\u201d (CEDIE), CONICET\u2014FEI\u2014Divisi\u00f3n de Endocrinolog\u00eda, Hospital de Ni\u00f1os Ricardo Guti\u00e9rrez , Buenos Aires,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9278-0523","authenticated-orcid":false,"given":"Kyla","family":"Ng Yin","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1683-7460","authenticated-orcid":false,"given":"Francesco","family":"d\u2019Aniello","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]},{"name":"School of Pediatrics, University of Rome Tor Vergata , Rome,","place":["Italy"]},{"name":"Endocrinology and Diabetes Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-6846","authenticated-orcid":false,"given":"Emma C","family":"Alexander","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]},{"name":"Paediatric Intensive Care Unit, St Mary\u2019s Hospital, Imperial College Healthcare NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Connolly","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6360-7246","authenticated-orcid":false,"given":"Rathi","family":"Prasad","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]},{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L","family":"Storr","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]},{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4891-2506","authenticated-orcid":false,"given":"Ruben H","family":"Willemsen","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-8521","authenticated-orcid":false,"given":"Leo","family":"Dunkel","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Endocrinology, University College London Hospital NHS Foundation Trust , London,","place":["UK"]},{"name":"UCL GOS Institute of Child Health, University College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-903X","authenticated-orcid":false,"given":"Sasha R","family":"Howard","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London,","place":["UK"]},{"name":"Department of Paediatric Endocrinology, Royal London Children\u2019s Hospital, Barts Health NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2025060312413300400_hoaf026-B1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejendo\/lvad166","article-title":"Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis","volume":"190","author":"Alexander","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2025060312413300400_hoaf026-B2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-8587(22)00339-4","article-title":"Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications","volume":"11","author":"Argente","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025060312413300400_hoaf026-B3","doi-asserted-by":"crossref","first-page":"1226839","DOI":"10.3389\/fendo.2023.1226839","article-title":"Key features of puberty onset and progression can help distinguish self-limited delayed puberty from congenital hypogonadotrophic hypogonadism","volume":"14","author":"Aung","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025060312413300400_hoaf026-B4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cen.12135","article-title":"Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3-year experience","volume":"79","author":"Aydogdu","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025060312413300400_hoaf026-B5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.fertnstert.2021.11.034","article-title":"Extended semen examinations in the sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: contributing to the understanding of the function of the male reproductive system","volume":"117","author":"Baldi","year":"2022","journal-title":"Fertil Steril"},{"key":"2025060312413300400_hoaf026-B6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0015-0282(98)00450-6","article-title":"Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism","volume":"71","author":"Barrio","year":"1999","journal-title":"Fertil Steril"},{"key":"2025060312413300400_hoaf026-B7","first-page":"112","article-title":"The effects of gonadotropin replacement therapy on metabolic parameters and body composition in men with idiopathic hypogonadotropic hypogonadism","volume":"48","author":"Bayram","year":"2016","journal-title":"Horm Metab Res"},{"key":"2025060312413300400_hoaf026-B8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2265.1999.00814.x","article-title":"Sexual dimorphism in circulating monomeric and dimeric inhibins in normal boys and girls from birth to puberty","volume":"51","author":"Bergad\u00e1","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025060312413300400_hoaf026-B9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1210\/jc.2007-2450","article-title":"Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function","volume":"93","author":"Boepple","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/clinem\/dgae439","article-title":"Serum concentrations of Inhibin B in healthy females and males throughout life","volume":"110","author":"Borelli-Kj\u00e6r","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0015-0282(01)02973-9","article-title":"Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism","volume":"77","author":"Bouloux","year":"2002","journal-title":"Fertil Steril"},{"key":"2025060312413300400_hoaf026-B12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/12.5.980","article-title":"Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism","volume":"12","author":"Burgu\u00e9s","year":"1997","journal-title":"Hum Reprod"},{"key":"2025060312413300400_hoaf026-B13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s40618-021-01556-x","article-title":"Predictors of reproductive and non-reproductive outcomes of gonadotropin mediated pubertal induction in male patients with congenital hypogonadotropic hypogonadism (CHH)","volume":"44","author":"Cangiano","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2025060312413300400_hoaf026-B14","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/s41467-024-49765-1","article-title":"Molecular insights into Sertoli cell function: how do metabolic disorders in childhood and adolescence affect spermatogonial fate?","volume":"15","author":"Cannarella","year":"2024","journal-title":"Nat Commun"},{"key":"2025060312413300400_hoaf026-B15","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1210\/jc.2008-0915","article-title":"Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells","volume":"93","author":"Chemes","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2605.1987.tb00358.x","article-title":"Proliferation of Sertoli cells during development of the human testis assessed by stereological methods","volume":"10","author":"Cortes","year":"1987","journal-title":"Int J Androl"},{"key":"2025060312413300400_hoaf026-B17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ejhg.2008.206","article-title":"Kallmann syndrome","volume":"17","author":"Dod\u00e9","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"2025060312413300400_hoaf026-B18","author":"Dunkel","year":"2021"},{"key":"2025060312413300400_hoaf026-B19","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1210\/jc.2013-2518","article-title":"Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism","volume":"98","author":"Dwyer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fendo.2019.00353","article-title":"Psychological aspects of congenital hypogonadotropic hypogonadism","volume":"10","author":"Dwyer","year":"2019","journal-title":"Front Endocrinol"},{"key":"2025060312413300400_hoaf026-B21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13023-021-01827-z","article-title":"Validating online approaches for rare disease research using latent class mixture modeling","volume":"16","author":"Dwyer","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2025060312413300400_hoaf026-B22","doi-asserted-by":"crossref","first-page":"e3955","DOI":"10.1210\/clinem\/dgac289","article-title":"A developmental perspective sheds light on reproductive differences between congenital and acquired hypogonadism","volume":"107","author":"Dwyer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B23","first-page":"133","article-title":"Current landscape of fertility induction in males with congenital hypogonadotropic hypogonadism","volume":"1540","author":"Dwyer","year":"2024","journal-title":"Ann NY Acad Sci"},{"key":"2025060312413300400_hoaf026-B24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11102-009-0203-1","article-title":"Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism","volume":"13","author":"Farhat","year":"2010","journal-title":"Pituitary"},{"key":"2025060312413300400_hoaf026-B25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/endrev\/bnab043","article-title":"New and consolidated therapeutic options for pubertal induction in hypogonadism: In-depth review of the literature","volume":"43","author":"Federici","year":"2022","journal-title":"Endocr Rev"},{"key":"2025060312413300400_hoaf026-B26","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1111\/j.1365-2605.2011.01210.x","article-title":"Early onset of primary hypogonadism revealed by serum anti-M\u00fcllerian hormone determination during infancy and childhood in trisomy 21","volume":"34","author":"Grinspon","year":"2011","journal-title":"Int J Androl"},{"key":"2025060312413300400_hoaf026-B27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2011.04297.x","article-title":"Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness","volume":"76","author":"Grinspon","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025060312413300400_hoaf026-B28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jpc.16540","article-title":"Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone","volume":"60","author":"Grob","year":"2024","journal-title":"J Paediatr Child Health"},{"key":"2025060312413300400_hoaf026-B29","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.21037\/apm-21-556","article-title":"The efficacy of pulsatile gonadotropin-releasing hormone therapy in male patients with hypogonadism caused by hypopituitarism","volume":"10","author":"Gu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2025060312413300400_hoaf026-B30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.urology.2013.06.041","article-title":"Assessment of deoxyribonucleic acid fragmentation index, testicular volume, semen parameters, and hormone profile in gonadotropin-treated men with hypogonadotropic hypogonadism","volume":"82","author":"Hosseinifar","year":"2013","journal-title":"Urology"},{"key":"2025060312413300400_hoaf026-B31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000438891","article-title":"Sex steroid and gonadotropin treatment in male delayed puberty","volume":"29","author":"Howard","year":"2016","journal-title":"Endocr Dev"},{"key":"2025060312413300400_hoaf026-B33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/humrep\/dei444","article-title":"Testis morphology in patients with idiopathic hypogonadotropic hypogonadism","volume":"21","author":"Kumar","year":"2006","journal-title":"Hum Reprod"},{"key":"2025060312413300400_hoaf026-B34","doi-asserted-by":"crossref","first-page":"e2812","DOI":"10.1210\/clinem\/dgac194","article-title":"Reproductive phenotypes in men with acquired or congenital hypogonadotropic hypogonadism: a comparative study","volume":"107","author":"Maione","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B35","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/dev158","article-title":"Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients","volume":"30","author":"Mao","year":"2015","journal-title":"Hum Reprod"},{"key":"2025060312413300400_hoaf026-B36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199702063360604","article-title":"Adult-onset idiopathic hypogonadotropic hypogonadism\u2014a treatable form of male infertility","volume":"336","author":"Nachtigall","year":"1997","journal-title":"N Engl J Med"},{"key":"2025060312413300400_hoaf026-B37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/cen.14436","article-title":"Novel rare variants in FGFR1 and clinical characteristics analysis in a series of congenital hypogonadotropic hypogonadism patients","volume":"95","author":"Nie","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025060312413300400_hoaf026-B38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ando.2022.06.002","article-title":"Potential impact of mini-puberty on fertility","volume":"83","author":"Nordenstr\u00f6m","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"key":"2025060312413300400_hoaf026-B39","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1530\/EJE-22-0073","article-title":"Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline","volume":"186","author":"Nordenstr\u00f6m","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2025060312413300400_hoaf026-B40","author":"Panelapp","year":"2023"},{"key":"2025060312413300400_hoaf026-B41","author":"Panelapp","year":"2023"},{"key":"2025060312413300400_hoaf026-B42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12020-021-02626-z","article-title":"ENDO-ERN expert opinion on the differential diagnosis of pubertal delay","volume":"71","author":"Persani","year":"2021","journal-title":"Endocrine"},{"key":"2025060312413300400_hoaf026-B43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/eje.1.02315","article-title":"Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome","volume":"156","author":"Raivio","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2025060312413300400_hoaf026-B44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/andr.262","article-title":"Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study","volume":"2","author":"Rastrelli","year":"2014","journal-title":"Andrology"},{"key":"2025060312413300400_hoaf026-B45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.2047-2927.2012.00008.x","article-title":"Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach","volume":"1","author":"Rey","year":"2013","journal-title":"Andrology"},{"key":"2025060312413300400_hoaf026-B46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/endrev\/bnae003","article-title":"Mini-puberty, physiological and disordered: consequences, and potential for therapeutic replacement","volume":"45","author":"Rohayem","year":"2024","journal-title":"Endocr Rev"},{"key":"2025060312413300400_hoaf026-B47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cen.13164","article-title":"Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism?\u2014a multicentre prospective study of hCG\/rFSH treatment outcomes during adolescence","volume":"86","author":"Rohayem","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025060312413300400_hoaf026-B48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/andr.12088","article-title":"Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism","volume":"3","author":"Rohayem","year":"2015","journal-title":"Andrology"},{"key":"2025060312413300400_hoaf026-B49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ando.2012.03.040","article-title":"Male acquired hypogonadotropic hypogonadism: diagnosis and treatment","volume":"73","author":"Salenave","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"key":"2025060312413300400_hoaf026-B50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/and.12480","article-title":"Treatment preferences and outcome in male hypogonadotropic hypogonadism: an Indian perspective","volume":"48","author":"Sanyal","year":"2016","journal-title":"Andrologia"},{"key":"2025060312413300400_hoaf026-B51","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1210\/clinem\/dgac145","article-title":"Corifollitropin alfa combined with human chorionic gonadotropin in adolescent boys with hypogonadotropic hypogonadism","volume":"107","author":"Shankar","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060312413300400_hoaf026-B52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cen.12435","article-title":"Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism","volume":"81","author":"Shiraishi","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025060312413300400_hoaf026-B54","doi-asserted-by":"crossref","first-page":"bvab172","DOI":"10.1210\/jendso\/bvab172","article-title":"Congenital micropenis: etiology and management","volume":"6","author":"Stancampiano","year":"2022","journal-title":"J Endocr Soc"},{"key":"2025060312413300400_hoaf026-B55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2164\/jandrol.109.008219","article-title":"Gonadotropin-regulated testicular RNA helicase (GRTH\/DDX25): a multifunctional protein essential for spermatogenesis","volume":"31","author":"Tsai-Morris","year":"2010","journal-title":"J Androl"},{"key":"2025060312413300400_hoaf026-B56","first-page":"147","article-title":"Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center","volume":"32","author":"Varimo","year":"2017","journal-title":"Hum Reprod"},{"key":"2025060312413300400_hoaf026-B57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-3016.2008.00969.x","article-title":"Assays with lower detection limits: implications for epidemiological investigations","volume":"22","author":"Whitcomb","year":"2008","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2025060312413300400_hoaf026-B58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11255-011-0065-0","article-title":"Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience","volume":"44","author":"Yang","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"2025060312413300400_hoaf026-B59","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1210\/er.2018-00116","article-title":"Clinical management of congenital hypogonadotropic hypogonadism","volume":"40","author":"Young","year":"2019","journal-title":"Endocr Rev"},{"key":"2025060312413300400_hoaf026-B60","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.fertnstert.2012.06.022","article-title":"Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis","volume":"98","author":"Zacharin","year":"2012","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hropen\/advance-article-pdf\/doi\/10.1093\/hropen\/hoaf026\/63166554\/hoaf026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2025\/2\/hoaf026\/63166554\/hoaf026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2025\/2\/hoaf026\/63166554\/hoaf026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:41:47Z","timestamp":1748968907000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoaf026\/8129573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoaf026","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"hoaf026"}}